XTL Biopharmaceuticals Ltd ADR (XTLB) — Cash Flow-to-Debt Ratio
XTL Biopharmaceuticals Ltd ADR (XTLB) has a Cash Flow-to-Debt Ratio of -10.73x as of December 2022, meaning its operating cash flow of $-2.01 Million could theoretically repay -11% of its total liabilities ($187.00K) in one year. Explore XTL Biopharmaceuticals Ltd ADR (XTLB) investment intensity to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
XTL Biopharmaceuticals Ltd ADR Cash Flow-to-Debt Ratio (2003–2024)
Historical debt coverage capacity for XTL Biopharmaceuticals Ltd ADR across 22 annual periods. Also explore XTL Biopharmaceuticals Ltd ADR (XTLB) total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for XTL Biopharmaceuticals Ltd ADR (2003–2024)
Year-by-year debt coverage analysis for XTL Biopharmaceuticals Ltd ADR. For market capitalisation and broader financial context, see XTLB market cap.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.52x | $-1.62 Million | $3.12 Million | ▲ +84.9% |
| 2023 | -3.43x | $-707.00K | $206.00K | ▲ +28.8% |
| 2022 | -4.82x | $-901.00K | $187.00K | ▼ -490.2% |
| 2021 | -0.82x | $-1.05 Million | $1.28 Million | ▲ +75.6% |
| 2020 | -3.35x | $-850.00K | $254.00K | ▲ +14.5% |
| 2019 | -3.91x | $-908.00K | $232.00K | ▼ -21.3% |
| 2018 | -3.23x | $-816.00K | $253.00K | ▼ -750.6% |
| 2017 | -0.38x | $-1.12 Million | $2.97 Million | ▲ +92.8% |
| 2016 | -5.25x | $-1.73 Million | $330.00K | ▼ -23.0% |
| 2015 | -4.27x | $-1.86 Million | $436.00K | ▼ -66.8% |
| 2014 | -2.56x | $-2.47 Million | $965.00K | ▼ -26.0% |
| 2013 | -2.03x | $-2.50 Million | $1.23 Million | ▼ -124.2% |
| 2012 | -0.91x | $-1.51 Million | $1.66 Million | ▲ +68.4% |
| 2011 | -2.86x | $-1.80 Million | $629.00K | ▼ -275.1% |
| 2010 | -0.76x | $-735.00K | $963.00K | ▲ +78.3% |
| 2009 | -3.51x | $-2.49 Million | $708.00K | ▲ +33.4% |
| 2008 | -5.28x | $-10.58 Million | $2.00 Million | ▼ -36.9% |
| 2007 | -3.86x | $-21.46 Million | $5.56 Million | ▼ -26.9% |
| 2006 | -3.04x | $-12.59 Million | $4.14 Million | ▼ -13.3% |
| 2005 | -2.68x | $-10.47 Million | $3.90 Million | ▼ -11.5% |
| 2004 | -2.41x | $-14.49 Million | $6.02 Million | ▲ +23.3% |
| 2003 | -3.14x | $-13.33 Million | $4.25 Million | — |